PELITAS Welcomes Tee Green to Board of Directors

A New Addition to the Board Represents New Depth in Leadership

Dallas, TX — April 1, 2019 — PELITAS (formerly known as DCS Global), the leader in Revenue Cycle Patient Access technology solutions, today announced that Tee Green, Chairman and CEO of 121G, LLC, has joined the Board of Directors. As an experienced software executive, investor, and board member.  Mr. Green extends the depth of leadership and experience of the PELITAS board.

“The growing consumerism of healthcare and the increasing complexity in reimbursement create unique demands on providers in their efforts to increase cash while also creating loyalty in their patient population,” said Green. “PELITAS represents a unique opportunity for providers to do both, better.”

Green started his career in banking operations upon graduation from Auburn University.  He was part of the founding team of Greenway Corporation where he led the sale of Greenway Corporation to the BISYS Group for $47.5 million.  Mr. Green remained with the BISYS Group in leadership roles including CEO of Greenway Medical Technologies. By way of organic growth and multiple acquisitions, Green led the company to the eventual merger of Greenway and two other companies which had over 2,000 employees and a $1b enterprise value. He continued as CEO of the combined companies until April of 2016.

“Tee is a dynamic leader and a pioneer of better technology in healthcare," said Steven Huddleston, CEO of PELITAS. "He is a pivotal addition to our board and we are excited to have him."
 
Green has a wide array of public and nonpublic board service with current positions within healthcare and technology related companies including PELITAS, Caravan Health, ReferralPoint, WellBox, GreenCourt, Sonic Tools, Clearview Installations, Mint Health, and StreamLine Health, where he serves as Chairman of the Board.

"I am honored to serve on the PELITAS Board of Directors," said Green. "Healthcare systems that choose PELITAS, and their consumer patients, have a bright future together."

About PELITAS
Patients and providers suffer from a complex and frustrating revenue cycle…an experience originating before care, at the point of access. Except those who choose PELITAS. A simple, quality experience for patients. An accurate encounter for providers. And amazingly, more cash…an outcome that actually cultivates patient loyalty. PELITAS (formerly known as DCS Global) is the leader in healthcare revenue cycle patient access technology solutions. Discover more at pelitas.com.

Contact for Inquiries
Peter Snell
214.810.6207
psnell@lumotiv.com

Pelitas (formerly DCS Global) Named 2019 Best in KLAS for Patient Access Solutions

Pelitas (formerly DCS Global) Named 2019 Best in KLAS for Patient Access Solutions

Recognition from independent, healthcare IT insights company affirms commitment to delivering superior solutions to help providers

DALLAS – January 31, 2019 – Pelitas, formerly DCS Global, (“the Company”), a leading provider of healthcare patient access and revenue cycle technology solutions, announced today that it has earned the 2019 Best in KLAS award for the Patient Access category. The award is based on customer comments and insights and reflects the Company’s close connection with and unmatched service to its clients. Healthcare leaders, and their patients, continue to achieve incomparable value by using the Pelitas technology platform.

“The real story here comes from the voice of the healthcare professionals we serve. The substantial outcomes they achieve in using Pelitas technology is paramount to how KLAS measures value, and it is an honor to be independently recognized as a decisive Best in KLAS leader helping our partners achieve superior results,” said Steven Huddleston, CEO of Pelitas. “That honor is shared by my colleagues, whose hard work and commitment to excellence is what powers our company.”

Adam Gale, President of KLAS, commented, “Best in KLAS raises the bar for healthcare technology. Providers and payers demand better performance, usability, and interoperability. Ultimately, Best in KLAS helps foster greater value in the healthcare technology market from which providers can select the tools they need to facilitate superior care and improved outcomes.”

Huddleston also noted that winners in the rapidly changing healthcare technology landscape will deliver comprehensive and integrated solutions that encompass robust analytic and patient insight capabilities. “Providers want partners who can integrate with existing EMR systems while providing innovative and seamless solutions that yield discernable value, as defined in terms of both financial results and patient experience.”

For the full "2019 Best in KLAS: Software & Services" report, visit: https://klasresearch.com/report/2019-best-in-klas-software-services/1473

About KLAS
KLAS is an independent research firm on a global mission to improve health care delivery by enabling providers and payers to be heard and counted. Working with thousands of health care professionals, KLAS gathers insights on software, services and medical equipment to deliver timely reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly represents the voice of health care professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.

About Pelitas
Pelitas is a leading provider of healthcare patient access and revenue cycle technology solutions. Healthcare providers maximize revenue and reduce inefficiencies throughout the revenue cycle with the flagship Pelitas platform iPAS (Integrated Patient Access Solutions). With iPAS, providers increase reimbursement and collection early in the revenue cycle by increasing the quality of patient registrations, maximizing point of service payments, and leveraging cloud-based design to facilitate electronic collaboration between the patient, provider, and payer. Discover more at www.pelitas.com.

Contact for Inquiries
Peter Snell
214.810.6207
psnell@lumotiv.com

DCS Global Appoints Dominick DeRosa as Chief Growth Officer

Dominick DeRosa, Chief Growth Officer

Dominick DeRosa, Chief Growth Officer

Healthcare Revenue Cycle Solutions Company Expands its Executive Team

DALLAS – January 23, 2019 – DCS Global (“the Company”), a leading provider of healthcare patient access and revenue cycle technology solutions, announced today that Dominick DeRosa has joined the Company as its Chief Growth Officer. Mr. DeRosa will have executive responsibility for sales, marketing and partnerships. This appointment is part of a continued strategic plan to rapidly expand the Company’s market share with its leading patient access solutions. DCS Global is a portfolio company of Tritium Partners.

Mr. DeRosa is a proven leader within the healthcare revenue cycle sector with a track record of building high-performing teams that drive growth and innovation. He most recently served as SVP of Commercial Strategy and Partnerships at nThrive, a healthcare services company. During his 10-year tenure at nThrive, Mr. DeRosa had responsibility for revenue cycle technology sales, client success and partnerships. Prior to that, he served as Sales Leader for CareMedic (Optum). Mr. DeRosa also spent 17 years with HBOC (McKesson), where he was responsible for an organization of 600 colleagues focused on commercial success in the healthcare EMR market, driving $1 billion in sales.

Steven Huddleston, CEO of DCS, commented, “Dominick is a seasoned healthcare IT growth executive with deep experience in developing, executing and leading multi-channel growth strategies for large and small healthcare businesses. His expertise in driving mutual success and efficiency as providers move to transform their revenue cycles and increase patient engagement will be invaluable to our future, and we are excited to have Dominick on our team.”

“I am proud to be part of the next chapter of DCS Global and build upon its roots in innovation and deep client commitment,” said Mr. DeRosa. “When we listen and respond to the needs of our clients, great things happen for the industry, the business and our team members.”

About DCS Global
DCS Global provides leading software and solutions to help healthcare providers maximize revenue and reduce inefficiencies throughout the revenue cycle. The company's innovative platform iPAS (Integrated Patient Access Solutions) is designed to enhance reimbursement and collection early on in the revenue cycle by increasing the quality of patient registrations, maximizing point of service payments, and using cloud-based technology to facilitate electronic collaboration between the patient, provider, and payer. With over 200 hospitals using its solutions, including large and small systems, academic medical centers, independents, and physician groups, DCS Global is uniquely positioned to improve the revenue cycle for all healthcare providers. Learn more at www.dcsglobal.com.

About Tritium Partners
Founded in 2013, Tritium Partners is a private equity firm focused on companies with exceptional growth potential. For over sixteen years, the founders of Tritium have deployed over $800 million of equity capital while partnering with talented founders and executives to build market-leading companies. Tritium’s approach emphasizes creating long-term value through strategic growth initiatives and acquisitions, with a focus on Internet and information services, supply chain and logistics, and financial and business services. For more information, please visit www.tritiumpartners.com.

Contact for Inquiries
Blicksilver Public Relations
Caroline Luz
203.656.2829
caroline@blicksilverpr.com

DCS Global Appoints Steven Huddleston as CEO

Steven Huddleston, CEO

Steven Huddleston, CEO

Provider of Patient Access Solutions Plans Rapid Revenue Cycle Innovation and New Market Expansion

DALLAS, Dec. 10, 2018 -- DCS Global ("the Company"), a leading provider of healthcare patient access and revenue cycle technology solutions, announced today that Steven Huddleston has joined the Company as its new CEO. This appointment is part of a broader strategic plan to rapidly expand the Company's market-leading solutions while introducing new products and services aimed at improving efficiency and satisfaction across patient access functions. DCS Global is a portfolio company of Tritium Partners.

Mr. Huddleston most recently served as President, Service Solutions and Chief Client Officer at nThrive, with revenue responsibility over all growth initiatives and operating responsibility over all service-delivery functions. Prior to that, he served as Managing Director in Accenture's US Healthcare Strategy practice, where he led a portfolio aimed at revenue cycle and reimbursement transformation through the thoughtful deployment of technology solutions and consumer-driven processes. Notably, Mr. Huddleston also spent 13 years with Hospital Corporation of America (HCA), where he was instrumental in the creation and launch of Parallon.

"I could not imagine a better time to join DCS Global as the market faces an unprecedented need for innovative patient access solutions to address both growing demand for improved outcomes for patients and sustained financial health for providers," said Mr. Huddleston. "I was impressed by DCS's commitment to flexible, cloud-based solutions that provide dramatic results demonstrated by high customer satisfaction and strong industry accolades. I am excited to lead the Company's effort to aggressively extend the market reach of its solutions."

Mr. Huddleston is a thought leader in the healthcare revenue cycle sector, with a proven record of guiding companies through periods of rapid growth, innovation and scale. He has worked with providers across the entire healthcare industry – from single-practice providers, to large academic medical centers, to global for-profit institutions – as these providers seek to change revenue cycle practices through broad-scale transformation that improves yield and growth.

"We are thrilled to welcome Steven to help lead our growing organization," said Manoj Chhabra, co-founder, President and Chief Innovation Officer of DCS Global. "We are confident in Steven's ability to lead the Company while we work together to advance our leading solutions and to ensure our clients continue to receive exceptional support and outcomes," said Babita Jain, cofounder and Chief Operating Officer of DCS Global.

Matt Bowman, Managing Partner of Tritium Partners, added, "Following our recent investment in DCS Global, we are thrilled to have Steven leading this next phase of the Company's growth. We conducted an extensive search to find the right executive with the requisite expertise, passion, and commitment to excellence for this exciting time as DCS extends its market awareness and product leadership."

About DCS Global
DCS Global provides software and solutions to help healthcare providers maximize revenue and reduce inefficiencies throughout the revenue cycle. The company’s innovative platform iPAS (Integrated Patient Access Solutions) is designed to enhance reimbursement and collection early on in the revenue cycle by increasing the quality of patient registrations, maximizing point of service payments, and using cloud-based technology to facilitate electronic collaboration between the patient, provider, and payer. With over 200 hospitals using its solutions, including large and small systems, academic medical centers, independents, and physician groups, DCS Global is uniquely positioned to improve the revenue cycle for all healthcare providers. Learn more at www.dcsglobal.com.

About Tritium Partners
Tritium Partners is a private equity firm focused on buyouts of growth companies in the lower middle market. For over a decade, the founders of Tritium have deployed over $800 million of equity capital while partnering with talented founders and executives to build market-leading companies. Tritium’s investment approach emphasizes acquiring majority positions in profitable companies and creating long-term value through internal growth initiatives and acquisitions. Learn more at www.tritiumpartners.com.

Contact for Inquiries
Caroline Luz Owen
Blicksilver Public Relations
203.656.2829
caroline@blicksilverpr.com

DCS Global receives growth investment from Tritium Partners

Will rapidly expand its leading patient access solutions for healthcare providers

Dallas, Texas – June 25, 2018 – DCS Global (“DCS”), a leading provider of revenue cycle management software, announced today it has received a growth investment from Tritium Partners. The investment will provide DCS with the resources to further increase the availability of its admission and financial-clearance solutions for healthcare providers looking to benefit from accelerated reimbursements, reduced denials, enhanced patient experience, and increased pre-service collections.

DCS offers a comprehensive suite of cloud-based, patient-access solutions to manage and optimize the revenue cycle for total reimbursement and efficiency, and its iPAS platform (Integrated Patient Access Solutions) is HFMA peer reviewed. Following the recapitalization, both Manoj Chhabra, CEO, and Babita Jain, COO, will remain with the company to focus on serving customers while bolstering its management, sales, and customer support teams to support the significant growth DCS is experiencing.

“We are excited to complete this transaction with the team at Tritium Partners in order to launch our next phase of transformational growth,” said Mr. Chhabra. “Their experience in helping businesses scale through times of dynamic growth and the financial resources provided by them will help us with our strategic plans of investing in new product innovation and pursuing market expansion,” added Ms. Jain.

Matt Bowman, Partner at Tritium Partners, commented, “DCS is the best-kept secret for healthcare providers needing front-end solutions to better address patient consumerism and payor reimbursement. The company was built by listening to and solving customer needs and that formula has fueled remarkable customer satisfaction and growth. We are excited to partner with management to help support the expansion of their market-leading products to a broader base of providers.”

In addition to providing capital to increase DCS’s market presence, significant resources will also be invested in new product advancements that will enhance the company’s leading end-to-end solutions for patient experience and revenue cycle efficiency including registration accuracy and identity verification, medical necessity and eligibility, patient estimates and payments, authorizations and order entry, and claim status and denial tracking.

“To-date, DCS has primarily grown through word of mouth, given its reputation for highly functional and impactful patient access products and its dedication to delivering high quality, personalized service to customers,” added David Lack, Managing Partner at Tritium Partners. “We are looking forward to supporting the company’s expansion plans while ensuring it maintains its product and innovation leadership.”

About DCS Global
DCS Global provides software and solutions to help healthcare providers maximize revenue and reduce inefficiencies throughout the revenue cycle. The company’s innovative platform iPAS (Integrated Patient Access Solutions) is designed to enhance reimbursement and collection early on in the revenue cycle by increasing the quality of patient registrations, maximizing point of service payments, and using cloud-based technology to facilitate electronic collaboration between the patient, provider, and payer. With over 200 hospitals using its solutions, including large and small systems, academic medical centers, independents, and physician groups, DCS Global is uniquely positioned to improve the revenue cycle for all healthcare providers. Learn more at www.dcsglobal.com.

About Tritium Partners
Tritium Partners is a private equity firm focused on buyouts of growth companies in the lower middle market. For over a decade, the founders of Tritium have deployed over $800 million of equity capital while partnering with talented founders and executives to build market-leading companies. Tritium’s investment approach emphasizes acquiring majority positions in profitable companies and creating long-term value through internal growth initiatives and acquisitions. Learn more at www.tritiumpartners.com.

Contact for Inquiries
Caroline Luz Owen
Blicksilver Public Relations
203.656.2829
caroline@blicksilverpr.com